[The value of anti-inflammatory effectiveness of Apranax 550 and Voltaren 50 after knee joint arthroscopic surgery].
The results are presented of the study of the effectiveness of non-steroid anti-inflammatory drugs (Apranax, Voltaren) on the basis of observation of 60 patients in a double blind trial after knee joint arthroscopic operations. The administration of Apranax 550 or Voltaren 50 within the period of 10 days after the operation decreased significantly the incidence of inflammatory reactions. Apranax 550 was acting more rapidly and more effectively in elimination of clinical signs and symptoms of inflammation, and the patients were not reporting any adverse effects.
Tylman
D
D
Instytutu Chirurgii Urazowej Ortopedii i Neurochirurgii Centrum Kształcenia Podyplomowego Wojskowej Ak. Med. im. gen. dyw. B. Szareckiego, Warszawie.
Kwiatkowski
K
K
Dymara
A
A
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects*; D004008:Diclofenac / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007719:Knee Joint / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000627:therapeutic use*; D010149:Postoperative Pain / Q000209:etiology / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac; D009288:Naproxen
Cena skuteczności przeciwzapalnej Apranaxu 550 i Voltarenu 50 po operacjach artroskopowych stawu kolanowego.